Nexalin Technology, Inc. (NXL)
NASDAQ: NXL · IEX Real-Time Price · USD
1.264
+0.024 (1.94%)
Jul 22, 2024, 10:08 AM EDT - Market open
Nexalin Technology Employees
Nexalin Technology had 6 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
6
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$26,477
Profits / Employee
-$823,575
Market Cap
9.59M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 6 | 0 | - |
Dec 31, 2022 | 6 | -4 | -40.00% |
Dec 31, 2021 | 10 | 6 | 150.00% |
Dec 31, 2020 | 4 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Zhongchao | 142 |
PAVmed | 107 |
Tonix Pharmaceuticals Holding | 103 |
Molecular Templates | 62 |
Elevai Labs | 18 |
MIRA Pharmaceuticals | 3 |
Silo Pharma | 3 |
Mangoceuticals | 3 |
NXL News
- 4 days ago - Nexalin Technology Selected to Join Industry Coalition: Breaking Barriers to Substance Use Recovery - GlobeNewsWire
- 20 days ago - Nexalin Technology Announces Closing of $5.2 Million Public Offering - GlobeNewsWire
- 24 days ago - Nexalin Technology Announces Pricing of $5.2 Million Public Offering - GlobeNewsWire
- 4 weeks ago - Nexalin Technology Awarded Key Patent Related to its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device for the Treatment of Alzheimer's and Dementia - GlobeNewsWire
- 5 weeks ago - Nexalin Technology and VolitionRX Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Accesswire
- 5 weeks ago - Nexalin Technology Announces Regulatory Approval to Sell Nexalin's Gen-2, 15 mA Neurostimulation Device by the Brazilian Health Regulatory Agency (Anvisa) - GlobeNewsWire
- 6 weeks ago - Nexalin Technology to Present at the Spring MicroCap Rodeo Conference on June 6th - GlobeNewsWire
- 7 weeks ago - FDA Provides Feedback and Reaches Consensus on Nexalin's Design for Planned Anxiety and Insomnia Clinical Studies of its Gen-3 HALO Clarity™ Headset Device - GlobeNewsWire